{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:38:27Z","timestamp":1754163507329,"version":"3.41.2"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Meningiomas are usually benign solitary intracranial tumors. In rare cases, atypical [World Health Organization (WHO) grade II) and anaplastic (WHO grade III) meningiomas can lead to distant metastases. Meningioma cells express somatostatin receptor subtype 2, providing a rationale for peptide receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogs in patients with aggressive meningiomas. A 68-year-old woman treated surgically in 2013 for a grade II cerebral meningioma presented 6 years later with pulmonary relapse. Complete response was achieved after 4 cycles of <jats:sup>177<\/jats:sup>Lu-DOTATATE PRRT, without recurrence after 3 years of follow-up.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005750","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:00:38Z","timestamp":1753938038000},"page":"e572-e574","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Complete Radiologic Response After 177Lu-DOTATATE Therapy in Treatment of a Lung Metastatic Intracranial Atypical Meningioma"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9068-9049","authenticated-orcid":false,"given":"Pauline","family":"Gillon","sequence":"first","affiliation":[{"name":"Radiotherapy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Institut Bergoni\u00e9, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaux","family":"Yaouanq","sequence":"additional","affiliation":[{"name":"Radiotherapy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Godbert","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, Institut Bergoni\u00e9, Bordeaux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3171\/2016.8.JNS16995","article-title":"Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review","volume":"127","author":"Graillon","year":"2017","journal-title":"J Neurosurg"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.3390\/curroncol29080438","article-title":"Somatostatin receptor theranostics for refractory meningiomas","volume":"29","author":"Salgues","year":"2022","journal-title":"Curr Oncol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2967\/jnumed.114.147256","article-title":"Somatostatin receptor\u2013targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial","volume":"56","author":"Marincek","year":"2015","journal-title":"J Nucl Med"},{"key":"R4-20250731","first-page":"1538","article-title":"Somatostatin receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE\/-TOC uptake","volume":"18","author":"Seystahl","year":"2016","journal-title":"Neuro Oncol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.2967\/jnumed.115.155853","article-title":"90Y-DOTATOC as a therapeutic option for complex recurrent or progressive meningiomas","volume":"56","author":"Gerster-Gilli\u00e9ron","year":"2015","journal-title":"J Nucl Med"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3390\/diagnostics12071666","article-title":"Somatostatin receptor targeted PET-imaging for diagnosis, radiotherapy planning and theranostics of meningiomas: a systematic review of the literature","volume":"12","author":"Filippi","year":"2022","journal-title":"Diagnostics"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mayocpiqo.2020.09.015","article-title":"Efficacy of 177Lu-dotatate therapy in the treatment of recurrent meningioma","volume":"5","author":"Zahid","year":"2021","journal-title":"Mayo Clin Proc Inn Qual Out"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1097\/RLU.0000000000002077","article-title":"Lung metastases of intracranial atypical meningioma diagnosed on post-therapeutic imaging after 177Lu-DOTATATE therapy","volume":"43","author":"Backhaus","year":"2018","journal-title":"Clin Nucl Med"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00259-022-06044-9","article-title":"Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma","volume":"50","author":"Minczeles","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:00:40Z","timestamp":1753938040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005750","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"type":"print","value":"0363-9762"},{"type":"electronic","value":"1536-0229"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"2024-11-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}